12,666 Shares in Colgate-Palmolive Company $CL Purchased by Friedenthal Financial

Friedenthal Financial purchased a new stake in Colgate-Palmolive Company (NYSE:CLFree Report) in the first quarter, Holdings Channel.com reports. The institutional investor purchased 12,666 shares of the company’s stock, valued at approximately $1,080,000.

Other hedge funds have also bought and sold shares of the company. Teacher Retirement System of Texas grew its stake in Colgate-Palmolive by 35.3% in the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock valued at $37,110,000 after acquiring an additional 122,634 shares during the period. GAMMA Investing LLC raised its position in Colgate-Palmolive by 114.2% during the fourth quarter. GAMMA Investing LLC now owns 23,329 shares of the company’s stock worth $1,843,000 after acquiring an additional 12,437 shares during the period. Grantham Mayo Van Otterloo & Co. LLC lifted its holdings in Colgate-Palmolive by 217.0% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,605 shares of the company’s stock valued at $3,246,000 after purchasing an additional 27,796 shares in the last quarter. Avior Wealth Management LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at $1,135,000. Finally, Flputnam Investment Management Co. grew its position in shares of Colgate-Palmolive by 7.4% in the fourth quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock valued at $15,881,000 after purchasing an additional 13,804 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $91.88 on Thursday. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. The stock has a market cap of $73.52 billion, a PE ratio of 35.75, a P/E/G ratio of 4.82 and a beta of 0.33. The stock has a 50 day moving average price of $87.76 and a 200 day moving average price of $86.92.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Equities research analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s payout ratio is currently 82.49%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Bank of America cut their target price on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research note on Friday, April 10th. Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. The Goldman Sachs Group reiterated a “buy” rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Royal Bank Of Canada reissued an “outperform” rating and set a $102.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

View Our Latest Research Report on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.